Abstract |
Transgenic rat mutation assays can be used to assess genotoxic properties of chemicals in target organs for carcinogenicity. Mutations in transgenes are genetically neutral and accumulate during a treatment period; thus, assays are suitable for assessing the genotoxic risk of chemicals using a repeated-dose treatment paradigm. However, only a limited number of such studies have been conducted. To examine the utility of transgenic rat assays in repeated-dose studies, we fed male and female Sprague-Dawley gpt delta rats with a 0.5% phenacetin-containing diet for 26 and 52 weeks. A long-term feeding of phenacetin is known to induce renal cancer in rats. Phenacetin administration for 52 weeks in males significantly increased gpt (point mutations) mutant frequency (MF) in the kidney, the target organ of carcinogenesis. In the liver, the nontarget organ of carcinogenesis, gpt MFs were significantly elevated in phenacetin treatment groups of both genders during 26- and 52-week treatments. Furthermore, sensitive to P2 interference (Spi(-)deletions) MF increased in the liver of both genders following 52-week treatment. MFs were higher after treatment for 52 weeks than after treatment for 26 weeks. Frequencies of phenacetin-induced mutations were higher in the liver than in the kidney, suggesting that the intensity of genotoxicity does not necessarily correlate with the induction of tumor formation. Results from gpt delta rat assays of repeated-dose treatments are extremely useful to elucidate the relationship between gene mutations and carcinogenesis in the target organ induced by cancer-causing agents.
|
Authors | Yuji Kawamura, Hiroyuki Hayashi, Kenichi Masumura, Satoshi Numazawa, Takehiko Nohmi |
Journal | Toxicology
(Toxicology)
Vol. 324
Pg. 10-7
(Oct 03 2014)
ISSN: 1879-3185 [Electronic] Ireland |
PMID | 25047350
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Analgesics, Non-Narcotic
- Hypoxanthine Phosphoribosyltransferase
- Phenacetin
|
Topics |
- Analgesics, Non-Narcotic
(toxicity)
- Animals
- Cell Transformation, Neoplastic
(chemically induced, genetics, metabolism)
- Female
- Hypoxanthine Phosphoribosyltransferase
(genetics, metabolism)
- Kidney
(drug effects, enzymology, pathology)
- Kidney Neoplasms
(chemically induced, genetics, metabolism)
- Liver
(drug effects, enzymology, pathology)
- Male
- Mutagenicity Tests
- Phenacetin
(toxicity)
- Point Mutation
(drug effects)
- Rats
- Rats, Sprague-Dawley
- Rats, Transgenic
- Risk Assessment
- Time Factors
|